The Verein zur Förderung der biomedizinischen und klinischen Forschung e.V. awarded five scientists from Dortmund, four from the Max Planck Institute of Molecular Physiology, at this year's Dortmund Biomedicine Summit at the MPI Dortmund on August 29th 2017.
August 31, 2017
The Dortmund Biomedicine Award is awarded to outstanding scientists since 1992. Its aim is to support biological and medicinal research and to improve the communication and cooperation between basic research and clinical research.
“One important aspect is to understand the cause of diseases like cancer and to target them specifically trough the development of innovative therapy strategies” stressed out by Prof. Dr. Jan Hengstler, director at the Leibnitz Research Centre for Working Environment and Human Factors and president of the “Verein zur Förderung der biomedizinischen und klinischen Forschung e.V.”. Young researchers from the MPI, Dr. Björn Papke, Dr. Eyad Kalawy Fansa and Lucas Robke were awarded in this context for the development of inhibitors that block cancer promoting processes. Dr. Alex Bird, research group leader at the MPI was awarded for the discovery of a protein responsible for the missegregation of DNA during the division of cancer cells and the underlying mechanism.
Another award was given to Prof. Dr. Dorothée Nashan, head of the dermatology clinic in Dortmund. Her team is investigating symptoms of stress as cause of cancer diagnosis and how to organize psychooncological care of patients.